Enzymatica AB (publ) (STO:ENZY)
2.740
-0.520 (-15.95%)
Mar 6, 2025, 3:00 PM CET
Enzymatica AB Revenue
In the year 2024, Enzymatica AB had annual revenue of 45.58M SEK, down -10.47%. Enzymatica AB had revenue of 17.16M in the quarter ending December 31, 2024, with 8.38% growth.
Revenue
45.58M
Revenue Growth
-10.47%
P/S Ratio
13.87
Revenue / Employee
2.17M
Employees
21
Market Cap
796.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.58M | -5.33M | -10.47% |
Dec 31, 2023 | 50.90M | 1.96M | 4.00% |
Dec 31, 2022 | 48.95M | -8.30M | -14.49% |
Dec 31, 2021 | 57.24M | -54.00M | -48.54% |
Dec 31, 2020 | 111.25M | 49.94M | 81.46% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.03B |
Getinge AB | 34.76B |
Sectra AB | 3.14B |
Camurus AB | 1.87B |
Medicover AB | 23.97B |
Vitrolife AB | 3.61B |
Bonesupport Holding AB | 898.73M |
Elekta AB | 17.88B |